A new Crispr-powered optical blood test detects lung cancer biomarkers at sub-attomolar levels, offering earlier molecular detection than conventional PCR or imaging.

Please visit Mainz Biomed’s official website for investors at mainzbiomed.com/investors/ for more information.

As AI content pollutes the web, a new attack vector opens in the battleground for cultural consensus. Research led by a Korean search company argues that as AI-generated pages encroach into search ...

Researchers now recognize eight different trajectories after COVID infection; some are severely ill many months later.

A Shenzhen University team has created a light-driven blood sensor that detects cancer-related microRNAs with high specificity, offering potential for early diagnosis.

On February 13, 2026, Mainz Biomed N.V. (the “Company”) entered into a securities purchase agreement for a 6.0 USD million private placement with investor David Lazar. The financing will be completed ...

Merck , known as MSD outside of the United States and Canada, today announced positive second RSV season findings from the ...